Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types



Newsletter Article


Tracking the FDA’s Drug Pricing Strategy

What actions has the Food and Drug Administration taken to further the Trump administration’s goal to bring down prescription drug prices? In a new post, former congressman Henry Waxman and other experts at Waxman Strategies present a detailed timeline of the FDA’s strategy on prices and highlight some of its key moves to inject competition into the growing market for biologic drugs.

Publication Details